We provide fully customized, GMP-compliant bioprocess equipment solutions dedicated to high-precision mRNA-LNP formulation and nanoparticle manufacturing, covering preclinical R&D, clinical trial production and commercial-scale mRNA vaccine manufacturing scenarios. All customized systems strictly comply with FDA cGMP, EU GMP and sterile biopharmaceutical processing standards, specifically optimized for the fragile biochemical properties of mRNA molecules and ultra-sensitive LNP self-assembly mechanisms. Adopting low-shear, low-pollution and high-precision process design principles, our audit-ready equipment portfolio addresses core technical challenges in lipid encapsulation, particle size control and activity retention, delivering stable and reproducible manufacturing infrastructure for mRNA-LNP bioproduction.
Our specialized mRNA-LNP process equipment features targeted structural optimization and ultra-precise process control to meet rigorous formulation specifications. The full product lineup includes customized low-shear mixing tanks, sterile buffer preparation skids, inline microfluidic formulation systems, temperature-locked storage vessels and enclosed sterile transfer units. All wetted components adopt medical-grade 316L stainless steel and ultra-smooth dead-zone-free polishing structure to eliminate nucleic acid residue and microbial contamination risks. Optimized laminar flow operation, constant-temperature microenvironment control and inert gas sealing protection effectively prevent mRNA degradation and LNP particle agglomeration, ensuring uniform particle size distribution, high encapsulation rate and consistent batch quality.
Covering full-lifecycle customized engineering and turnkey delivery services, our scope includes process-oriented equipment scheme design, functional module customization, parameter calibration matching, sanitary pipeline integration, factory FAT testing, on-site installation and SAT commissioning, process method verification and complete GMP validation document support. All equipment supports automated CIP cleaning and SIP sterilization to achieve full-process closed and aseptic production, avoiding manual intervention-induced contamination and process deviation. Reserved intelligent monitoring and data acquisition interfaces realize full-process traceability of temperature, flow rate, pressure and mixing parameters, fully meeting global regulatory audit and quality management requirements.
Empowered by in-depth mRNA-LNP biomanufacturing experience, our customized equipment solutions deliver unique technical and economical advantages for advanced nucleic acid drug production. Professional process customization eliminates equipment over-design and functional mismatch, greatly improving formulation efficiency and finished product qualification rate. Flexible modular configuration supports seamless switching between small-batch R&D verification and large-scale commercial production, adapting to rapid product iteration and capacity adjustment. We help biotech and pharmaceutical enterprises build professional, compliant and high-stability mRNA-LNP formulation production systems to accelerate new drug registration, clinical promotion and global commercialization layout.
